Fust Matthew K
Neumora Therapeutics, Inc. Common Stock · Director
Fust Matthew K is listed in public filings as director. This Fust Matthew K insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Neumora Therapeutics, Inc. Common Stock (NMRA), Ultragenyx Pharmaceutical Inc (RARE), Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX), and Atara Biotherapeutics, Inc. (ATRA). Investors use Fust Matthew K's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $716k16k shares | SellSep 26, 2025 | $44.75 | -- |